| For: | Jia L, Zhang MH. Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats. World J Gastroenterol 2005; 11(6): 908-911 [PMID: 15682492 DOI: 10.3748/wjg.v11.i6.908] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i6/908.htm |
| Number | Citing Articles |
| 1 |
SAIDAN DING, WEILONG HUANG, YIRU YE, JIANJING YANG, JIANGNAN HU, XIAOBIN WANG, LEPING LIU, QIN LU, YUANSHAO LIN. Elevated intracranial dopamine impairs the glutamate-nitric oxide-cyclic guanosine monophosphate pathway in cortical astrocytes in rats with minimal hepatic encephalopathy. Molecular Medicine Reports 2014; 10(3) doi: 10.3892/mmr.2014.2386
|
| 2 |
Xiao‐Jun Cai, Lei Wang, Chun‐Mei Hu. Retracted: Efficacy of different drugs in the treatment of minimal hepatic encephalopathy: A network meta‐analysis involving 826 patients based on 10 randomized controlled trials. Journal of Cellular Biochemistry 2018; 119(10) doi: 10.1002/jcb.26886
|
| 3 |
Janine Donaldson, Tomasz Jacek, Piotr Wychowański, Kamil Zaworski, Dominika Szkopek, Jarosław Woliński, Danica Grujic, Stefan Pierzynowski, Kateryna Pierzynowska. Rat Model of Endogenous and Exogenous Hyperammonaemia Induced by Different Diets. International Journal of Molecular Sciences 2025; 26(5) doi: 10.3390/ijms26051818
|
| 4 |
Ming Luo, Jian-Yang Guo, Wu-Kui Cao. Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis. World Journal of Gastroenterology 2015; 21(41): 11815-11824 doi: 10.3748/wjg.v21.i41.11815
|
| 5 |
Laura E. Halpin, Bryan K. Yamamoto. Peripheral Ammonia as a Mediator of Methamphetamine Neurotoxicity. The Journal of Neuroscience 2012; 32(38) doi: 10.1523/JNEUROSCI.2530-12.2012
|
| 6 |
Laura E Halpin, Nicole A Northrop, Bryan K Yamamoto. Ammonia Mediates Methamphetamine-Induced Increases in Glutamate and Excitotoxicity. Neuropsychopharmacology 2014; 39(4) doi: 10.1038/npp.2013.306
|
| 7 |
Jie Gao, Huifang Chen, Liuyue Xu, Shanglin Li, Huijun Yan, Lifang Jiang, Wenli Cheng, Zhenyou Jiang. Effects of Intestinal Microorganisms on Influenza-Infected Mice with Antibiotic-Induced Intestinal Dysbiosis, through the TLR7 Signaling Pathway. Frontiers in Bioscience-Landmark 2023; 28(3) doi: 10.31083/j.fbl2803043
|
| 8 |
Rania R. Abdelaziz, Rehab S. Abdelrahman, Marwa E. Abdelmageed. SB332235, a CXCR2 antagonist, ameliorates thioacetamide-induced hepatic encephalopathy through modulation of the PI3K/AKT pathways in rats. NeuroToxicology 2022; 92 doi: 10.1016/j.neuro.2022.08.005
|
| 9 |
Stephen M. Riordan, Roger Williams. The intestinal flora and bacterial infection in cirrhosis. Journal of Hepatology 2006; 45(5) doi: 10.1016/j.jhep.2006.08.001
|
| 10 |
Richard G McGee, Anouk Bakens, Kerrie Wiley, Stephen M Riordan, Angela C Webster, Richard G McGee. Cochrane Database of Systematic Reviews. 2011; doi: 10.1002/14651858.CD008716.pub2
|
| 11 |
Barjesh Chander Sharma, Jatinderpal Singh. Probiotics in management of hepatic encephalopathy. Metabolic Brain Disease 2016; 31(6) doi: 10.1007/s11011-016-9826-x
|
| 12 |
Sheng Xu, Min Zhao, Qinjian Wang, Zhihua Xu, Binhui Pan, Yilang Xue, Zebin Dai, Sisi Wang, Zhanxiong Xue, Fangyan Wang, Changlong Xu. Effectiveness of Probiotics and Prebiotics Against Acute Liver Injury: A Meta-Analysis. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.739337
|
| 13 |
Al Shaima G. Abd El Salam, Nesma A. Abd Elrazik. Cinnamaldehyde/lactulose combination therapy alleviates thioacetamide-induced hepatic encephalopathy via targeting P2X7R-mediated NLRP3 inflammasome signaling. Life Sciences 2024; 344 doi: 10.1016/j.lfs.2024.122559
|
| 14 |
Nicole A. Northrop, Laura E. Halpin, Bryan K. Yamamoto. Peripheral ammonia and blood brain barrier structure and function after methamphetamine. Neuropharmacology 2016; 107 doi: 10.1016/j.neuropharm.2016.03.018
|
| 15 |
Eamonn M.M. Quigley, Catherine Stanton, Eileen F. Murphy. The gut microbiota and the liver. Pathophysiological and clinical implications. Journal of Hepatology 2013; 58(5) doi: 10.1016/j.jhep.2012.11.023
|
| 16 |
Jing Liu, Enkhchimeg Lkhagva, Hea-Jong Chung, Hyeon-Jin Kim, Seong-Tshool Hong. The Pharmabiotic Approach to Treat Hyperammonemia. Nutrients 2018; 10(2) doi: 10.3390/nu10020140
|
| 17 |
Xiao-Li Xie, Jie-Tao He, Zheng-Tao Wang, Huan-Qin Xiao, Wen-Tao Zhou, Si-Hao Du, Ye Xue, Qi Wang. Lactulose attenuates METH-induced neurotoxicity by alleviating the impaired autophagy, stabilizing the perturbed antioxidant system and suppressing apoptosis in rat striatum. Toxicology Letters 2018; 289 doi: 10.1016/j.toxlet.2018.03.015
|
| 18 |
Charles Nicaise, Deborah Prozzi, Eric Viaene, Christophe Moreno, Thierry Gustot, Eric Quertinmont, Pieter Demetter, Valérie Suain, Philippe Goffin, Jacques Devière, Pascal Hols. Control of acute, chronic, and constitutive hyperammonemia by wild‐type and genetically engineered Lactobacillus plantarum in rodents†. Hepatology 2008; 48(4) doi: 10.1002/hep.22445
|
| 19 |
Puneeta Tandon, Karli Moncrief, Karen Madsen, Marie C. Arrieta, Richard J. Owen, Vince G. Bain, Winnie W. Wong, Mang M. Ma. Effects of probiotic therapy on portal pressure in patients with cirrhosis: a pilot study. Liver International 2009; 29(7) doi: 10.1111/j.1478-3231.2009.02020.x
|
| 20 |
Ming Luo, Lei Li, Er‐Na Yang, Wu‐Kui Cao. Relationship between interleukin‐6 and ammonia in patients with minimal hepatic encephalopathy due to liver cirrhosis. Hepatology Research 2012; 42(12) doi: 10.1111/j.1872-034X.2012.01047.x
|
| 21 |
Mirjam Looijer-van Langen, Karen Madsen. Bioactive Foods in Promoting Health. 2010; doi: 10.1016/B978-0-12-374938-3.00007-4
|
| 22 |
Miranda Claire Gilbert, Tahereh Setayesh, Yu-Jui Yvonne Wan. The contributions of bacteria metabolites to the development of hepatic encephalopathy. Liver Research 2023; 7(4) doi: 10.1016/j.livres.2022.11.005
|
| 23 |
F Al-Yassir, H Holail, Z Olama. Effect of Different Lebanese Probiotics on the Growth and Some Biochemical Parameters of the Experimental Rats. Journal of Pure and Applied Microbiology 2018; 12(1) doi: 10.22207/JPAM.12.1.47
|
| 24 |
Jie Gao, Rui Nie, Hong Chang, Wei Yang, Qian Ren. A meta-analysis of microbiome therapies for hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 2023; 35(9) doi: 10.1097/MEG.0000000000002596
|
| 25 |
Xiao-Li Xie, Wen-Tao Zhou, Kai-Kai Zhang, Li-Jian Chen, Qi Wang. METH-Induced Neurotoxicity Is Alleviated by Lactulose Pretreatment Through Suppressing Oxidative Stress and Neuroinflammation in Rat Striatum. Frontiers in Neuroscience 2018; 12 doi: 10.3389/fnins.2018.00802
|
| 26 |
Xueyan Lin, Zhengchao Zhang, Yi Lin, Shiyun Lu, Rongrong Chen, Wan-Long Chuang. The effects of rifaximin and lactulose on the gut-liver-brain axis in rats with minimal hepatic encephalopathy. PLOS One 2025; 20(6) doi: 10.1371/journal.pone.0325988
|
| 27 |
Xiang-Feng Liu, Hai-Jiao Long, Xiong-Ying Miao, Guo-Li Liu, Hong-Liang Yao. Fisetin inhibits liver cancer growth in a mouse model: Relation to dopamine receptor. Oncology Reports 2017; 38(1) doi: 10.3892/or.2017.5676
|
| 28 |
Yosra A. Hussien, Dina F. Mansour, Somaia A. Nada, Sahar S. Abd El-Rahman, Rania M. Abdelsalam, Amina S. Attia, Dalia M. El-Tanbouly. Linagliptin attenuates thioacetamide-induced hepatic encephalopathy in rats: Modulation of C/EBP-β and CX3CL1/Fractalkine, neuro-inflammation, oxidative stress and behavioral defects. Life Sciences 2022; 295 doi: 10.1016/j.lfs.2022.120378
|
| 29 |
Praveen Rishi, Swapandeep Kaur Mavi, Sushma Bharrhan, Geeta Shukla, Rupinder Tewari. Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiology Ecology 2009; 69(2) doi: 10.1111/j.1574-6941.2009.00703.x
|
| 30 |
Gwendolyn Jankowski. Lactulose. Journal of Exotic Pet Medicine 2009; 18(2) doi: 10.1053/j.jepm.2009.04.009
|
| 31 |
Saidan Ding, Jianjing Yang, Xueli Huang, Leping Liu, Jiangnan Hu, Zhu Xu, Qichuan Zhuge. Dopamine Burden Induced the Inactivation of Sonic Hedgehog Signaling to Cognitive Decline in Minimal Hepatic Encephalopathy. Aging and disease 2017; 8(4) doi: 10.14336/AD.2016.1123
|
| 32 |
Saidan Ding, Jianjing Yang, Leping Liu, Yiru Ye, Xuebao Wang, Jiangnan Hu, Bicheng Chen, Qichuan Zhuge. Elevated dopamine induces minimal hepatic encephalopathy by activation of astrocytic NADPH oxidase and astrocytic protein tyrosine nitration. The International Journal of Biochemistry & Cell Biology 2014; 55 doi: 10.1016/j.biocel.2014.09.003
|
| 33 |
Yan Yan Jin, Parul Singh, Hea-Jong Chung, Seong-Tschool Hong. Blood Ammonia as a Possible Etiological Agent for Alzheimer’s Disease. Nutrients 2018; 10(5) doi: 10.3390/nu10050564
|
| 34 |
Lucia Giuli, Marta Maestri, Francesco Santopaolo, Maurizio Pompili, Francesca Romana Ponziani. Gut Microbiota and Neuroinflammation in Acute Liver Failure and Chronic Liver Disease. Metabolites 2023; 13(6) doi: 10.3390/metabo13060772
|
| 35 |
Kathryn D. Fischer, Lori A. Knackstedt, Paul A. Rosenberg. Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior. Neurochemistry International 2021; 144 doi: 10.1016/j.neuint.2020.104896
|
| 36 |
M. Sonal Sekhar, M.K. Unnikrishnan, Gabriel Sunil Rodrigues, Chiranjay Mukhopadhyay. Synbiotic formulation of probiotic and lactulose combination for hepatic encephalopathy treatment: A realistic hope?. Medical Hypotheses 2013; 81(2) doi: 10.1016/j.mehy.2013.05.016
|
| 37 |
Sara M. Baraka, Dalia O. Saleh, Neveen S. Ghaly, Farouk R. Melek, Amina A. Gamal el Din, Wagdy K.B. Khalil, Mahmoud M. Said, Amina M. Medhat. Flavonoids from Barnebydendron riedelii leaf extract mitigate thioacetamide-induced hepatic encephalopathy in rats: The interplay of NF-κB/IL-6 and Nrf2/HO-1 signaling pathways. Bioorganic Chemistry 2020; 105 doi: 10.1016/j.bioorg.2020.104444
|